Signature Genetics
Signature Genetics offers two types of reports; the Drug-Gene Report and the All-Inclusive Report. Both reports have been designed to:
The Drug-Gene Report
The All-Inclusive Report
"Please note that the All-Inclusive Report is not available in the USA"
- present personalized and clinically-relevant pharmacogenetic information in a concise and easy to understand format.
- alert the physician to a patient's risk for adverse events and/or lack of efficacy for specific drugs (view list) and/or dosages based on CYP genotype.
- minimize "trial and error" dosing resulting from "one-size-fits-all" approach to drug development.
- help achieve quicker treatment results.
- be used both retrospectively and prospectively for drugs from our Pharmacogenetics Drug List (view list).
The Drug-Gene Report
- provides flexible and economical pricing based on drug-gene information for one, two, or three CYP genes. The number of genes to be tested will vary depending on the drug(s) chosen from our Pharmacogenetics Drug List (view list)
- identifies CYP450-based drug-drug interactions in your current drug regimen.
- includes free updates for one year. Updates can be ordered if changes are made to your drug regimen.
The All-Inclusive Report
- provides personalized and clinically-relevant information based on your genetic test results for 4 key CYP450 genes.
- identifies CYP450-based drug-drug interactions in your current drug regimen.
- identifies CYP450-based drug-lifestyle interactions (smoking, caffeine and grapefruit).
- provides information on the contribution of CYP450 genes to the metabolism of currently marketed hormonal supplements, herbals and recreational drugs.
- includes a Personalized Drug Management Guide for a panel of over 200 drugs (this list continues to grow and is updated accordingly).
- includes free updates for one year. Updates can be ordered if changes are made to your drug regimen
"Please note that the All-Inclusive Report is not available in the USA"



